Diagnostic PCR Panel in Children With Acute Gastrointestinal Symptoms

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 16
SponsorUniversity of Oulu

About this trial

This investigator-initiated randomized controlled trial compares the clinical impact of real time PCR of fecal samples in children with acute gastrointestinal symptoms at a pediatric emergency room. Specifically, the trial compares immediate testing of fecal samples using a multiplex PCR panel to a a control group with delayed test results.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Child or adolescent < 16 years of age

Visiting pediatric ED

Presence of gastrointestinal symptom or symptoms (diarrhea, vomiting or abdominal pain)

Disqualifiers

Need of cardiopulmonary resuscitation at the ED

Need of immediate transfer to the intensive care unit

Hemato-oncological disease

Severe immunosuppression

Trial design

Design model

Parallel

Treatments tested in this trial

  • Multiplex PCR gastrointestinal panel

    Diagnostic test

    Intervention includes a rapid use of multiplex PCR panel for gastrointestinal pathogens of fecal samples from children with acute gastrointestinal symptoms evaluated at a pediatric emergency room

Treatment groups

526 Participants
are divided into 2 treatment groups
Group A: Intervention: Rapid diagnostics groupOther 1 intervention
Group B: Control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Impact on clinical decision making

Primary outcome comprises the proportion of participants with 1) targeted antimicrobial therapy based on PCR results 2) untargeted antimicrobial therapy avoided based on PCR result, OR 3) specific clinical follow up planned based on PCR result, namely EHEC infection

Time frame
72 hours from initial contact at the ED

Secondary outcomes

1

Proportion of children with correctly targeted antimicrobial therapy

Proportion of children with correctly targeted antimicrobial therapy based on PCR results

Time frame
72 hours from initial contact at the ED
2

Proportion of children needing hospitalization or specific follow up

Proportion of children needing hospitalization or specific follow up

Time frame
72 hours from initial contact at the ED
3

Time to receive the laboratory results

Time (hours) from the initial presentation at the ED to the laboratory results given to the clinicians

Time frame
7 days from the initial presentation to the ED
4

Length of stay

Length of hospital stay, time (hours) before discharge

Time frame
30 days from the presentation to the ED

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Oulu

Lead sponsor

Oulu University Hospital

Collaborator

This trial is not recruiting at the moment. You can still explore other options: